{
    "ticker": "IMPLQ",
    "name": "Implant Sciences Corporation",
    "description": "Implant Sciences Corporation was a leading provider of explosives and narcotics trace detection systems for aviation, border security, and law enforcement applications. Founded in 1984, the company specialized in developing advanced technology solutions aimed at ensuring safety and security in public spaces. Implant Sciences developed the QS-B220, a highly sensitive device used for detecting trace amounts of explosives on various surfaces, which gained recognition for its reliability and speed in identifying threats. The company's commitment to innovation led to products that were utilized by government agencies and private security firms worldwide. Implant Sciences aimed to enhance security protocols through cutting-edge detection solutions, contributing to the global fight against terrorism and enhancing public safety. Despite facing market challenges, the company was known for its dedication to research and development, continuously improving its product offerings to meet the evolving needs of security personnel. Implant Sciences' mission was to provide state-of-the-art technology to protect people and assets in an increasingly uncertain world.",
    "industry": [
        "Security Technology",
        "Defense"
    ],
    "headquarters": "Wilmington, Massachusetts, USA",
    "founded": "1984",
    "website": "http://www.implantsciences.com",
    "key_executives": [
        {
            "name": "G. Scott Smith",
            "position": "President & CEO"
        },
        {
            "name": "Joseph K. W. Wong",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Trace Detection Systems",
            "products": [
                "QS-B220 Explosives Detector",
                "QS-Detection Systems"
            ]
        }
    ],
    "seo": {
        "meta_title": "Implant Sciences Corporation | Advanced Security Solutions",
        "meta_description": "Learn about Implant Sciences Corporation, a leader in explosives and narcotics detection technology. Explore their innovative solutions for enhancing public safety.",
        "keywords": [
            "Implant Sciences",
            "Explosives Detection",
            "Narcotics Detection",
            "Security Technology",
            "Public Safety",
            "QS-B220"
        ]
    },
    "faq": [
        {
            "question": "What does Implant Sciences specialize in?",
            "answer": "Implant Sciences specializes in explosives and narcotics trace detection systems."
        },
        {
            "question": "When was Implant Sciences founded?",
            "answer": "Implant Sciences was founded in 1984."
        },
        {
            "question": "Where is the headquarters of Implant Sciences located?",
            "answer": "Implant Sciences is headquartered in Wilmington, Massachusetts, USA."
        },
        {
            "question": "What is the QS-B220?",
            "answer": "The QS-B220 is a highly sensitive explosives detection device developed by Implant Sciences."
        }
    ],
    "competitors": [
        "OSI",
        "AVAV",
        "GD"
    ],
    "related_stocks": [
        "LMT",
        "NOC",
        "RTN",
        "HII"
    ]
}